Pharma & Healthcare

Global Venous Thromboembolism Drug Market Insights, Forecast to 2030

Venous Thromboembolism includes both deep vein thrombosis (DVT) and pulmonary embolism (PE).
The global Venous Thromboembolism Drug market is projected to grow from US$ 2406 million in 2024 to US$ 3272.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Venous Thromboembolism Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Venous Thromboembolism Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Venous Thromboembolism Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Venous Thromboembolism Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Venous Thromboembolism Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Venous Thromboembolism Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Boehringer Ingelheim
Daiichi Sankyo
J&J
Sanofi
Altor Bioscience
Armetheon
Aspen Pharma
BioInvent
eXIthera Pharmaceuticals
Gamma Therapeutics
Segment by Type
Heparin
Apixaban
Dabigatran
Rivaroxaban
Edaxaban
Warfarin
Segment by Application
Hospital
Clinic
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Venous Thromboembolism Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Venous Thromboembolism Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Venous Thromboembolism Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Venous Thromboembolism Drug Product Introduction
1.2 Market by Type
1.2.1 Global Venous Thromboembolism Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Heparin
1.2.3 Apixaban
1.2.4 Dabigatran
1.2.5 Rivaroxaban
1.2.6 Edaxaban
1.2.7 Warfarin
1.3 Market by Application
1.3.1 Global Venous Thromboembolism Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Venous Thromboembolism Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Venous Thromboembolism Drug Revenue by Region
2.2.1 Global Venous Thromboembolism Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Venous Thromboembolism Drug Revenue by Region (2019-2024)
2.2.3 Global Venous Thromboembolism Drug Revenue by Region (2025-2030)
2.2.4 Global Venous Thromboembolism Drug Revenue Market Share by Region (2019-2030)
2.3 Global Venous Thromboembolism Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Venous Thromboembolism Drug Sales by Region
2.4.1 Global Venous Thromboembolism Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Venous Thromboembolism Drug Sales by Region (2019-2024)
2.4.3 Global Venous Thromboembolism Drug Sales by Region (2025-2030)
2.4.4 Global Venous Thromboembolism Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Venous Thromboembolism Drug Sales by Manufacturers
3.1.1 Global Venous Thromboembolism Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Venous Thromboembolism Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Venous Thromboembolism Drug in 2023
3.2 Global Venous Thromboembolism Drug Revenue by Manufacturers
3.2.1 Global Venous Thromboembolism Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Venous Thromboembolism Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Venous Thromboembolism Drug Revenue in 2023
3.3 Global Key Players of Venous Thromboembolism Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Venous Thromboembolism Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Venous Thromboembolism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Venous Thromboembolism Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Venous Thromboembolism Drug, Product Offered and Application
3.8 Global Key Manufacturers of Venous Thromboembolism Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Venous Thromboembolism Drug Sales by Type
4.1.1 Global Venous Thromboembolism Drug Historical Sales by Type (2019-2024)
4.1.2 Global Venous Thromboembolism Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Venous Thromboembolism Drug Sales Market Share by Type (2019-2030)
4.2 Global Venous Thromboembolism Drug Revenue by Type
4.2.1 Global Venous Thromboembolism Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Venous Thromboembolism Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Venous Thromboembolism Drug Revenue Market Share by Type (2019-2030)
4.3 Global Venous Thromboembolism Drug Price by Type
4.3.1 Global Venous Thromboembolism Drug Price by Type (2019-2024)
4.3.2 Global Venous Thromboembolism Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Venous Thromboembolism Drug Sales by Application
5.1.1 Global Venous Thromboembolism Drug Historical Sales by Application (2019-2024)
5.1.2 Global Venous Thromboembolism Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Venous Thromboembolism Drug Sales Market Share by Application (2019-2030)
5.2 Global Venous Thromboembolism Drug Revenue by Application
5.2.1 Global Venous Thromboembolism Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Venous Thromboembolism Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Venous Thromboembolism Drug Revenue Market Share by Application (2019-2030)
5.3 Global Venous Thromboembolism Drug Price by Application
5.3.1 Global Venous Thromboembolism Drug Price by Application (2019-2024)
5.3.2 Global Venous Thromboembolism Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Venous Thromboembolism Drug Market Size by Type
6.1.1 US & Canada Venous Thromboembolism Drug Sales by Type (2019-2030)
6.1.2 US & Canada Venous Thromboembolism Drug Revenue by Type (2019-2030)
6.2 US & Canada Venous Thromboembolism Drug Market Size by Application
6.2.1 US & Canada Venous Thromboembolism Drug Sales by Application (2019-2030)
6.2.2 US & Canada Venous Thromboembolism Drug Revenue by Application (2019-2030)
6.3 US & Canada Venous Thromboembolism Drug Market Size by Country
6.3.1 US & Canada Venous Thromboembolism Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Venous Thromboembolism Drug Sales by Country (2019-2030)
6.3.3 US & Canada Venous Thromboembolism Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Venous Thromboembolism Drug Market Size by Type
7.1.1 Europe Venous Thromboembolism Drug Sales by Type (2019-2030)
7.1.2 Europe Venous Thromboembolism Drug Revenue by Type (2019-2030)
7.2 Europe Venous Thromboembolism Drug Market Size by Application
7.2.1 Europe Venous Thromboembolism Drug Sales by Application (2019-2030)
7.2.2 Europe Venous Thromboembolism Drug Revenue by Application (2019-2030)
7.3 Europe Venous Thromboembolism Drug Market Size by Country
7.3.1 Europe Venous Thromboembolism Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Venous Thromboembolism Drug Sales by Country (2019-2030)
7.3.3 Europe Venous Thromboembolism Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Venous Thromboembolism Drug Market Size
8.1.1 China Venous Thromboembolism Drug Sales (2019-2030)
8.1.2 China Venous Thromboembolism Drug Revenue (2019-2030)
8.2 China Venous Thromboembolism Drug Market Size by Application
8.2.1 China Venous Thromboembolism Drug Sales by Application (2019-2030)
8.2.2 China Venous Thromboembolism Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Venous Thromboembolism Drug Market Size by Type
9.1.1 Asia Venous Thromboembolism Drug Sales by Type (2019-2030)
9.1.2 Asia Venous Thromboembolism Drug Revenue by Type (2019-2030)
9.2 Asia Venous Thromboembolism Drug Market Size by Application
9.2.1 Asia Venous Thromboembolism Drug Sales by Application (2019-2030)
9.2.2 Asia Venous Thromboembolism Drug Revenue by Application (2019-2030)
9.3 Asia Venous Thromboembolism Drug Sales by Region
9.3.1 Asia Venous Thromboembolism Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Venous Thromboembolism Drug Revenue by Region (2019-2030)
9.3.3 Asia Venous Thromboembolism Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Venous Thromboembolism Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Venous Thromboembolism Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Overview
11.1.3 Bayer Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bayer Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 BMS
11.2.1 BMS Company Information
11.2.2 BMS Overview
11.2.3 BMS Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 BMS Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BMS Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Boehringer Ingelheim Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Information
11.4.2 Daiichi Sankyo Overview
11.4.3 Daiichi Sankyo Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Daiichi Sankyo Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Daiichi Sankyo Recent Developments
11.5 J&J
11.5.1 J&J Company Information
11.5.2 J&J Overview
11.5.3 J&J Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 J&J Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 J&J Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sanofi Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Altor Bioscience
11.7.1 Altor Bioscience Company Information
11.7.2 Altor Bioscience Overview
11.7.3 Altor Bioscience Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Altor Bioscience Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Altor Bioscience Recent Developments
11.8 Armetheon
11.8.1 Armetheon Company Information
11.8.2 Armetheon Overview
11.8.3 Armetheon Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Armetheon Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Armetheon Recent Developments
11.9 Aspen Pharma
11.9.1 Aspen Pharma Company Information
11.9.2 Aspen Pharma Overview
11.9.3 Aspen Pharma Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Aspen Pharma Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aspen Pharma Recent Developments
11.10 BioInvent
11.10.1 BioInvent Company Information
11.10.2 BioInvent Overview
11.10.3 BioInvent Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 BioInvent Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BioInvent Recent Developments
11.11 eXIthera Pharmaceuticals
11.11.1 eXIthera Pharmaceuticals Company Information
11.11.2 eXIthera Pharmaceuticals Overview
11.11.3 eXIthera Pharmaceuticals Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 eXIthera Pharmaceuticals Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 eXIthera Pharmaceuticals Recent Developments
11.12 Gamma Therapeutics
11.12.1 Gamma Therapeutics Company Information
11.12.2 Gamma Therapeutics Overview
11.12.3 Gamma Therapeutics Venous Thromboembolism Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Gamma Therapeutics Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Gamma Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Venous Thromboembolism Drug Industry Chain Analysis
12.2 Venous Thromboembolism Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Venous Thromboembolism Drug Production Mode & Process
12.4 Venous Thromboembolism Drug Sales and Marketing
12.4.1 Venous Thromboembolism Drug Sales Channels
12.4.2 Venous Thromboembolism Drug Distributors
12.5 Venous Thromboembolism Drug Customers
13 Market Dynamics
13.1 Venous Thromboembolism Drug Industry Trends
13.2 Venous Thromboembolism Drug Market Drivers
13.3 Venous Thromboembolism Drug Market Challenges
13.4 Venous Thromboembolism Drug Market Restraints
14 Key Findings in The Global Venous Thromboembolism Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Venous Thromboembolism Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Heparin
Table 3. Major Manufacturers of Apixaban
Table 4. Major Manufacturers of Dabigatran
Table 5. Major Manufacturers of Rivaroxaban
Table 6. Major Manufacturers of Edaxaban
Table 7. Major Manufacturers of Warfarin
Table 8. Global Venous Thromboembolism Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Venous Thromboembolism Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Venous Thromboembolism Drug Revenue by Region (2019-2024) & (US$ Million)
Table 11. Global Venous Thromboembolism Drug Revenue by Region (2025-2030) & (US$ Million)
Table 12. Global Venous Thromboembolism Drug Revenue Market Share by Region (2019-2024)
Table 13. Global Venous Thromboembolism Drug Revenue Market Share by Region (2025-2030)
Table 14. Global Venous Thromboembolism Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global Venous Thromboembolism Drug Sales by Region (2019-2024) & (K Units)
Table 16. Global Venous Thromboembolism Drug Sales by Region (2025-2030) & (K Units)
Table 17. Global Venous Thromboembolism Drug Sales Market Share by Region (2019-2024)
Table 18. Global Venous Thromboembolism Drug Sales Market Share by Region (2025-2030)
Table 19. Global Venous Thromboembolism Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 20. Global Venous Thromboembolism Drug Sales Share by Manufacturers (2019-2024)
Table 21. Global Venous Thromboembolism Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 22. Global Venous Thromboembolism Drug Revenue Share by Manufacturers (2019-2024)
Table 23. Global Key Players of Venous Thromboembolism Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 24. Venous Thromboembolism Drug Price by Manufacturers 2019-2024 (US$/Unit)
Table 25. Global Venous Thromboembolism Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Venous Thromboembolism Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Drug as of 2023)
Table 27. Global Key Manufacturers of Venous Thromboembolism Drug, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Venous Thromboembolism Drug, Product Offered and Application
Table 29. Global Key Manufacturers of Venous Thromboembolism Drug, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Venous Thromboembolism Drug Sales by Type (2019-2024) & (K Units)
Table 32. Global Venous Thromboembolism Drug Sales by Type (2025-2030) & (K Units)
Table 33. Global Venous Thromboembolism Drug Sales Share by Type (2019-2024)
Table 34. Global Venous Thromboembolism Drug Sales Share by Type (2025-2030)
Table 35. Global Venous Thromboembolism Drug Revenue by Type (2019-2024) & (US$ Million)
Table 36. Global Venous Thromboembolism Drug Revenue by Type (2025-2030) & (US$ Million)
Table 37. Global Venous Thromboembolism Drug Revenue Share by Type (2019-2024)
Table 38. Global Venous Thromboembolism Drug Revenue Share by Type (2025-2030)
Table 39. Venous Thromboembolism Drug Price by Type (2019-2024) & (US$/Unit)
Table 40. Global Venous Thromboembolism Drug Price Forecast by Type (2025-2030) & (US$/Unit)
Table 41. Global Venous Thromboembolism Drug Sales by Application (2019-2024) & (K Units)
Table 42. Global Venous Thromboembolism Drug Sales by Application (2025-2030) & (K Units)
Table 43. Global Venous Thromboembolism Drug Sales Share by Application (2019-2024)
Table 44. Global Venous Thromboembolism Drug Sales Share by Application (2025-2030)
Table 45. Global Venous Thromboembolism Drug Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Venous Thromboembolism Drug Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Venous Thromboembolism Drug Revenue Share by Application (2019-2024)
Table 48. Global Venous Thromboembolism Drug Revenue Share by Application (2025-2030)
Table 49. Venous Thromboembolism Drug Price by Application (2019-2024) & (US$/Unit)
Table 50. Global Venous Thromboembolism Drug Price Forecast by Application (2025-2030) & (US$/Unit)
Table 51. US & Canada Venous Thromboembolism Drug Sales by Type (2019-2024) & (K Units)
Table 52. US & Canada Venous Thromboembolism Drug Sales by Type (2025-2030) & (K Units)
Table 53. US & Canada Venous Thromboembolism Drug Revenue by Type (2019-2024) & (US$ Million)
Table 54. US & Canada Venous Thromboembolism Drug Revenue by Type (2025-2030) & (US$ Million)
Table 55. US & Canada Venous Thromboembolism Drug Sales by Application (2019-2024) & (K Units)
Table 56. US & Canada Venous Thromboembolism Drug Sales by Application (2025-2030) & (K Units)
Table 57. US & Canada Venous Thromboembolism Drug Revenue by Application (2019-2024) & (US$ Million)
Table 58. US & Canada Venous Thromboembolism Drug Revenue by Application (2025-2030) & (US$ Million)
Table 59. US & Canada Venous Thromboembolism Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. US & Canada Venous Thromboembolism Drug Revenue by Country (2019-2024) & (US$ Million)
Table 61. US & Canada Venous Thromboembolism Drug Revenue by Country (2025-2030) & (US$ Million)
Table 62. US & Canada Venous Thromboembolism Drug Sales by Country (2019-2024) & (K Units)
Table 63. US & Canada Venous Thromboembolism Drug Sales by Country (2025-2030) & (K Units)
Table 64. Europe Venous Thromboembolism Drug Sales by Type (2019-2024) & (K Units)
Table 65. Europe Venous Thromboembolism Drug Sales by Type (2025-2030) & (K Units)
Table 66. Europe Venous Thromboembolism Drug Revenue by Type (2019-2024) & (US$ Million)
Table 67. Europe Venous Thromboembolism Drug Revenue by Type (2025-2030) & (US$ Million)
Table 68. Europe Venous Thromboembolism Drug Sales by Application (2019-2024) & (K Units)
Table 69. Europe Venous Thromboembolism Drug Sales by Application (2025-2030) & (K Units)
Table 70. Europe Venous Thromboembolism Drug Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe Venous Thromboembolism Drug Revenue by Application (2025-2030) & (US$ Million)
Table 72. Europe Venous Thromboembolism Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 73. Europe Venous Thromboembolism Drug Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe Venous Thromboembolism Drug Revenue by Country (2025-2030) & (US$ Million)
Table 75. Europe Venous Thromboembolism Drug Sales by Country (2019-2024) & (K Units)
Table 76. Europe Venous Thromboembolism Drug Sales by Country (2025-2030) & (K Units)
Table 77. China Venous Thromboembolism Drug Sales by Type (2019-2024) & (K Units)
Table 78. China Venous Thromboembolism Drug Sales by Type (2025-2030) & (K Units)
Table 79. China Venous Thromboembolism Drug Revenue by Type (2019-2024) & (US$ Million)
Table 80. China Venous Thromboembolism Drug Revenue by Type (2025-2030) & (US$ Million)
Table 81. China Venous Thromboembolism Drug Sales by Application (2019-2024) & (K Units)
Table 82. China Venous Thromboembolism Drug Sales by Application (2025-2030) & (K Units)
Table 83. China Venous Thromboembolism Drug Revenue by Application (2019-2024) & (US$ Million)
Table 84. China Venous Thromboembolism Drug Revenue by Application (2025-2030) & (US$ Million)
Table 85. Asia Venous Thromboembolism Drug Sales by Type (2019-2024) & (K Units)
Table 86. Asia Venous Thromboembolism Drug Sales by Type (2025-2030) & (K Units)
Table 87. Asia Venous Thromboembolism Drug Revenue by Type (2019-2024) & (US$ Million)
Table 88. Asia Venous Thromboembolism Drug Revenue by Type (2025-2030) & (US$ Million)
Table 89. Asia Venous Thromboembolism Drug Sales by Application (2019-2024) & (K Units)
Table 90. Asia Venous Thromboembolism Drug Sales by Application (2025-2030) & (K Units)
Table 91. Asia Venous Thromboembolism Drug Revenue by Application (2019-2024) & (US$ Million)
Table 92. Asia Venous Thromboembolism Drug Revenue by Application (2025-2030) & (US$ Million)
Table 93. Asia Venous Thromboembolism Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 94. Asia Venous Thromboembolism Drug Revenue by Region (2019-2024) & (US$ Million)
Table 95. Asia Venous Thromboembolism Drug Revenue by Region (2025-2030) & (US$ Million)
Table 96. Asia Venous Thromboembolism Drug Sales by Region (2019-2024) & (K Units)
Table 97. Asia Venous Thromboembolism Drug Sales by Region (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Type (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Type (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Type (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Type (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Application (2019-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Application (2025-2030) & (K Units)
Table 104. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Application (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Application (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 107. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Country (2019-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue by Country (2025-2030) & (US$ Million)
Table 109. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Country (2019-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales by Country (2025-2030) & (K Units)
Table 111. Bayer Company Information
Table 112. Bayer Description and Major Businesses
Table 113. Bayer Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Bayer Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Bayer Recent Developments
Table 116. BMS Company Information
Table 117. BMS Description and Major Businesses
Table 118. BMS Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. BMS Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. BMS Recent Developments
Table 121. Boehringer Ingelheim Company Information
Table 122. Boehringer Ingelheim Description and Major Businesses
Table 123. Boehringer Ingelheim Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Boehringer Ingelheim Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Boehringer Ingelheim Recent Developments
Table 126. Daiichi Sankyo Company Information
Table 127. Daiichi Sankyo Description and Major Businesses
Table 128. Daiichi Sankyo Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Daiichi Sankyo Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Daiichi Sankyo Recent Developments
Table 131. J&J Company Information
Table 132. J&J Description and Major Businesses
Table 133. J&J Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. J&J Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. J&J Recent Developments
Table 136. Sanofi Company Information
Table 137. Sanofi Description and Major Businesses
Table 138. Sanofi Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Sanofi Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Sanofi Recent Developments
Table 141. Altor Bioscience Company Information
Table 142. Altor Bioscience Description and Major Businesses
Table 143. Altor Bioscience Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. Altor Bioscience Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Altor Bioscience Recent Developments
Table 146. Armetheon Company Information
Table 147. Armetheon Description and Major Businesses
Table 148. Armetheon Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Armetheon Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Armetheon Recent Developments
Table 151. Aspen Pharma Company Information
Table 152. Aspen Pharma Description and Major Businesses
Table 153. Aspen Pharma Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Aspen Pharma Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Aspen Pharma Recent Developments
Table 156. BioInvent Company Information
Table 157. BioInvent Description and Major Businesses
Table 158. BioInvent Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. BioInvent Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. BioInvent Recent Developments
Table 161. eXIthera Pharmaceuticals Company Information
Table 162. eXIthera Pharmaceuticals Description and Major Businesses
Table 163. eXIthera Pharmaceuticals Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. eXIthera Pharmaceuticals Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. eXIthera Pharmaceuticals Recent Developments
Table 166. Gamma Therapeutics Company Information
Table 167. Gamma Therapeutics Description and Major Businesses
Table 168. Gamma Therapeutics Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. Gamma Therapeutics Venous Thromboembolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Gamma Therapeutics Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Venous Thromboembolism Drug Distributors List
Table 174. Venous Thromboembolism Drug Customers List
Table 175. Venous Thromboembolism Drug Market Trends
Table 176. Venous Thromboembolism Drug Market Drivers
Table 177. Venous Thromboembolism Drug Market Challenges
Table 178. Venous Thromboembolism Drug Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Venous Thromboembolism Drug Product Picture
Figure 2. Global Venous Thromboembolism Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Venous Thromboembolism Drug Market Share by Type in 2023 & 2030
Figure 4. Heparin Product Picture
Figure 5. Apixaban Product Picture
Figure 6. Dabigatran Product Picture
Figure 7. Rivaroxaban Product Picture
Figure 8. Edaxaban Product Picture
Figure 9. Warfarin Product Picture
Figure 10. Global Venous Thromboembolism Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global Venous Thromboembolism Drug Market Share by Application in 2023 & 2030
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Venous Thromboembolism Drug Report Years Considered
Figure 15. Global Venous Thromboembolism Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Venous Thromboembolism Drug Revenue 2019-2030 (US$ Million)
Figure 17. Global Venous Thromboembolism Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 18. Global Venous Thromboembolism Drug Revenue Market Share by Region (2019-2030)
Figure 19. Global Venous Thromboembolism Drug Sales 2019-2030 ((K Units)
Figure 20. Global Venous Thromboembolism Drug Sales Market Share by Region (2019-2030)
Figure 21. US & Canada Venous Thromboembolism Drug Sales YoY (2019-2030) & (K Units)
Figure 22. US & Canada Venous Thromboembolism Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Europe Venous Thromboembolism Drug Sales YoY (2019-2030) & (K Units)
Figure 24. Europe Venous Thromboembolism Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 25. China Venous Thromboembolism Drug Sales YoY (2019-2030) & (K Units)
Figure 26. China Venous Thromboembolism Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Asia (excluding China) Venous Thromboembolism Drug Sales YoY (2019-2030) & (K Units)
Figure 28. Asia (excluding China) Venous Thromboembolism Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales YoY (2019-2030) & (K Units)
Figure 30. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 31. The Venous Thromboembolism Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 32. The Top 5 and 10 Largest Manufacturers of Venous Thromboembolism Drug in the World: Market Share by Venous Thromboembolism Drug Revenue in 2023
Figure 33. Global Venous Thromboembolism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 34. Global Venous Thromboembolism Drug Sales Market Share by Type (2019-2030)
Figure 35. Global Venous Thromboembolism Drug Revenue Market Share by Type (2019-2030)
Figure 36. Global Venous Thromboembolism Drug Sales Market Share by Application (2019-2030)
Figure 37. Global Venous Thromboembolism Drug Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Venous Thromboembolism Drug Sales Market Share by Type (2019-2030)
Figure 39. US & Canada Venous Thromboembolism Drug Revenue Market Share by Type (2019-2030)
Figure 40. US & Canada Venous Thromboembolism Drug Sales Market Share by Application (2019-2030)
Figure 41. US & Canada Venous Thromboembolism Drug Revenue Market Share by Application (2019-2030)
Figure 42. US & Canada Venous Thromboembolism Drug Revenue Share by Country (2019-2030)
Figure 43. US & Canada Venous Thromboembolism Drug Sales Share by Country (2019-2030)
Figure 44. U.S. Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 45. Canada Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 46. Europe Venous Thromboembolism Drug Sales Market Share by Type (2019-2030)
Figure 47. Europe Venous Thromboembolism Drug Revenue Market Share by Type (2019-2030)
Figure 48. Europe Venous Thromboembolism Drug Sales Market Share by Application (2019-2030)
Figure 49. Europe Venous Thromboembolism Drug Revenue Market Share by Application (2019-2030)
Figure 50. Europe Venous Thromboembolism Drug Revenue Share by Country (2019-2030)
Figure 51. Europe Venous Thromboembolism Drug Sales Share by Country (2019-2030)
Figure 52. Germany Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 53. France Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 54. U.K. Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 55. Italy Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 56. Russia Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 57. China Venous Thromboembolism Drug Sales Market Share by Type (2019-2030)
Figure 58. China Venous Thromboembolism Drug Revenue Market Share by Type (2019-2030)
Figure 59. China Venous Thromboembolism Drug Sales Market Share by Application (2019-2030)
Figure 60. China Venous Thromboembolism Drug Revenue Market Share by Application (2019-2030)
Figure 61. Asia Venous Thromboembolism Drug Sales Market Share by Type (2019-2030)
Figure 62. Asia Venous Thromboembolism Drug Revenue Market Share by Type (2019-2030)
Figure 63. Asia Venous Thromboembolism Drug Sales Market Share by Application (2019-2030)
Figure 64. Asia Venous Thromboembolism Drug Revenue Market Share by Application (2019-2030)
Figure 65. Asia Venous Thromboembolism Drug Revenue Share by Region (2019-2030)
Figure 66. Asia Venous Thromboembolism Drug Sales Share by Region (2019-2030)
Figure 67. Japan Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 68. South Korea Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 69. China Taiwan Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 70. Southeast Asia Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 71. India Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Venous Thromboembolism Drug Revenue Share by Country (2019-2030)
Figure 77. Middle East, Africa and Latin America Venous Thromboembolism Drug Sales Share by Country (2019-2030)
Figure 78. Brazil Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Mexico Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 80. Turkey Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 81. Israel Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 82. GCC Countries Venous Thromboembolism Drug Revenue (2019-2030) & (US$ Million)
Figure 83. Venous Thromboembolism Drug Value Chain
Figure 84. Venous Thromboembolism Drug Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies